Fulijia (301371.SZ): The clinical trial filing for the restructured Type III humanized collagen patch has been completed.

Zhtng Cijng APP Xn, F'r ji (301371.SZ) gnggo, gngs zi yny chn pn "zhngz xng rnyun hu jioyun dngbn ti flio" tnggu gi chnpn lngh shyn suyu zhngxn lnl wiyunhu de lnl shnch, bng zi Hilngjing shng yopn jind gunl j wnchng fn zhngxn Pnjn Lioyu Bosh Hu yyun de ylio qxi lngh shyn bi'n, gngs zi yny chn pn "zhngz xng rnyun hu jioyun dngbn ti flio" yjng ky kizhn lngh shyn. Zhitong Finance APP News, Fuerjia (301371.SZ) announced that the company's research product "recombinant type III humanized collagen dressing" has passed the ethical review of all central ethics committees of the clinical trials of this product, and has completed the medical device clinical trial filing at Liaoyou Baoshihua Hospital in Panjin, Heilongjiang Province, under the supervision of the drug administration of the medical device clinical trials, the company's research product "recombinant type III humanized collagen dressing" can now conduct clinical trials.